Clinical Register Studying the therApeutic Patient Population With Multifocal Atherosclerosis in the Russian Federation and Eurasian Countries

Status: Completed
Location: See location...
Study Type: Observational
SUMMARY

Аn international, multicenter, non-interventional real-life clinical practice Register studying the Actual therapeutic patient population with Multifocal Atherosclerosis in the Russian Federation and Eurasian countries

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Men or women aged 18 and older at the time of data registration; Presence of 2 or more of the following factors

‣ Coronary arteries atherosclerosis (atherosclerosis revealed by means of coronary angiography and/or a history of type I myocardial infarction and/or elective PCI and/or CABG and/or angina pectoris with ischemia according to stress test results, history of CHD);

⁃ Lower extremity arteries atherosclerosis (atherosclerotic plaques revealed by ultrasound, and/or ABI \<0.9, and/or a history of revascularization, and/or a history of amputation associated due to chronic lower extremities arterial insufficiency);

⁃ Atherosclerosis of brachiocephalic arteries or renal arteries (presence of atherosclerotic plaques according to US data and/or history of revascularization and/or history of atherothrombotic stroke or TIA in the absence of known AF);

⁃ Atherosclerosis of renal arteries or abdominal aorta (presence of atherosclerotic plaques according to US data and/or history of revascularization).

∙ Presence of one or more of the following atherosclerotic risk factors:

• Anamnestic data on dyslipidemia with LDL cholesterol levels above 4.9 mmol/L or total cholesterol levels above 8.0 mmol/L;

• Presence of confirmed familial hypercholesterolemia;

• Current smoker status or history of smoking;

• Overweight (BMI≥ 25 kg/m2);

• Presence of arterial hypertension;

• Presence of established type 2 diabetes mellitus;

• Presence of an established diagnosis of prediabetes;

• Presence of CKD stage 3a and higher (GFR \<60 ml / min / 1.73 m2).

Locations
Other Locations
Russian Federation
Eurasian Association of Therapists
Moscow
Time Frame
Start Date: 2022-02-01
Completion Date: 2024-01-31
Participants
Target number of participants: 3059
Treatments
Patients with MFA
Patients with MFA confirmed by ultrasound examination, ABI or using clinical and medical history data.
Patients with a history of established isolated coronary artery disease
The criterion for inclusion of patients in the present study is the diagnosed ischemic heart disease.
Sponsors
Leads: Eurasian Association of Therapists

This content was sourced from clinicaltrials.gov